Eco-Colordoppler – Manuale didattico
An interdisciplinary manual featuring images, annotated diagrams, and review questions to support intuitive learning of color Doppler ultrasound and echocardiography.
Read More
An interdisciplinary manual featuring images, annotated diagrams, and review questions to support intuitive learning of color Doppler ultrasound and echocardiography.
Read More
A structured didactic manual with images, anatomical diagrams, quizzes, and practical tips designed to guide learners step by step through the fundamentals of ultrasound imaging.
Read More
Verduci Editore sends warm holiday wishes and announces the summer closure from August 6th to August 21st.
Read More
The study compares olfactory rehabilitation therapy with Palmitoylethanolamide and Luteolin treatment in post-COVID patients. Preliminary data show a significant recovery of olfactory function within two months.
Read More
The updated second edition of the “Compendio di Neuroriabilitazione” includes twelve new chapters, expanded sections on technology and cognitive disorders, and content tailored for professionals in the neurorehabilitation field.
Read More
Season’s Greetings from Verduci Editore. During the holiday period, our offices will remain closed from December 24 to January 1.
Read More
The full event video is available, including simultaneous Italian translation. A meeting dedicated to longevity research and to the presentation of the Italian edition of David Sinclair’s book “Lifespan”.
Read More
Introductory text presenting Barry Sears’ book on diet-induced silent inflammation, its link with major chronic diseases and the nutritional strategies proposed to prevent and resolve it, aiming to extend healthy lifespan.
Read More
Camillo Ricordi’s introduction to the Italian edition of David Sinclair’s Lifespan, presenting ageing as a potentially reversible disease and exploring the role of epigenetics, novel anti-ageing molecules and the ethical imperative of extending healthy lifespan.
Read More
Real-life case series of four severe ICU COVID-19 patients treated with eculizumab: all achieved clinical recovery, with marked CRP reduction and a mean disease duration of about 13 days, supporting the potential role of anti-complement C5 therapy in severe cases.
Read More